Stay current on changes and developments in corporate law with a wide variety of resources and tools.
By Che Odom
March 7 — The number of companies announcing plans for initial public offerings continues to grow this year, but only a handful have actually gone public, according to data from Bloomberg Law: Corporate Transactions.
Since Jan. 1, only five companies have completed their IPOs this year, down more than 80 percent from this time last year. Of those five, biotech company Syndax Pharmaceuticals Inc.'s IPO is the latest to price on Feb. 23.
At the same time, about 50 companies have announced plans for an IPO since Jan. 1, and many remain in the pipeline from 2015, including issuances from BATs Global Markets Inc. and SoulCycle Inc.
All of this year's IPOs that have priced come from the health-care sector.
New rulemaking out of the Securities and Exchange Commission, alternative methods of financing and market volatility may be behind the low numbers .
To highlight just how lackluster this year's issuances have been, there were 41 IPOs completed in the first quarter of 2015, according to PricewaterhouseCoopers US data. The 2015 numbers represented a 42 percent decrease compared to the first quarter of 2014, when 71 IPOs were completed in what PwC described as a “robust” period for the offerings.
To contact the reporter on this story: Che Odom in Washington at firstname.lastname@example.org
To contact the editor responsible for this story: Yin Wilczek at email@example.com
|Issuer||Date Announced||Offer Size||Left Lead Bookrunner||Legal Adviser||Offer Stage||Offer Price|
|Red Fish Holdings Inc.||02/19/2016||$0.20M||—||—||Pending||—|
|Healthcare Royalty Trust Plc||02/17/2016||$286.24M||—||—||Pending||—|
|Corporate Coaches Inc.||02/12/2016||$0.20M||—||Hateley & Hampton||Pending||—|
|Far Sighted Media Inc.||02/11/2016||$1.98M||—||Adam S Tracy Esq||Pending||—|
|Sensus Healthcare Inc.||02/10/2016||$23.00M||Joseph Gunnar & Co.||Gunster Yoakley & Stewart PA||Pending||—|
|US Foods Holding Corp.||02/09/2016||$100.00M||—||Jenner & Block LLC||Pending||—|
|GRCR Partners Inc.||02/08/2016||$0.25M||—||Daniel H Luciano Esq||Pending||—|
|Colony Global Acquisition Corp.||02/05/2016||$300.00M||Credit Suisse||Skadden Arps Slate Meagher & Flom||Pending||—|
|Leng Universal Inc.||02/02/2016||$10.00M||—||Adam S Tracy Esq||Pending||—|
|Moleculin Biotech Inc.||02/01/2016||$12.00M||Bonwick Capital Partners LLC||Schiff Hardin LLP||Pending||—|
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)